The Venture Codex Logo

The Venture Codex

Japanese Agency for Medical Research and Development

1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan

Overview

Independent organization for medical research and development.

Founded

2015

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Grant
Series A
Series B

Geographic focus

Japan
United States

Sector focus

—

Investment portfolio

6rounds
NAMEDATESIZE
RegCell
Sep 2026Led
$66 MSeries A
Celaid Therapeutics
Oct 2025Participated
$7 MSeries B
FerroptoCure
Sep 2025Participated
$7 MSeries A
RevolKa
Jun 2025Led
$0.36 MGrant
Shinobi Therapeutics
Aug 2024Led
$59 MGrant
Restore Vision
Dec 2023Participated
$13 MSeries A
RegCell
Sep 2026Led
$66 MSeries A
Celaid Therapeutics
Oct 2025Participated
$7 MSeries B
FerroptoCure
Sep 2025Participated
$7 MSeries A
RevolKa
Jun 2025Led
$0.36 MGrant
Shinobi Therapeutics
Aug 2024Led
$59 MGrant
Restore Vision
Dec 2023Participated
$13 MSeries A
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Japanese Agency for Medical Research and Development: 6 funding rounds are recorded in the selected participation categories.All available history.
Japanese Agency for Medical Research and Development: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A12
Series B01
Grant20

Monthly Deal Activity

Japanese Agency for Medical Research and Development: 6 deals are recorded across 35 months.All available history.
Japanese Agency for Medical Research and Development: 6 deals are recorded across 35 months. All available history
MonthDeals
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '251
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Japanese Agency for Medical Research and Development: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Japanese Agency for Medical Research and Development: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6
Manufacturing1

Deal Size Distribution

Japanese Agency for Medical Research and Development: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Japanese Agency for Medical Research and Development: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M2
$10M-$25M1
$25M-$50M0
$50M-$100M2
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Japanese Agency for Medical Research and Development: Japan has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Japanese Agency for Medical Research and Development: Japan has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
Japan5
United States1
Japanese Agency for Medical Research and Development: 19 co-investors are shown, with Osaka University Venture Capital sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Japanese Agency for Medical Research and Development: 19 co-investors are shown, with Osaka University Venture Capital sharing 3 recorded deals. All available history
Co-investorShared deals
Osaka University Venture Capital3
Japan Science and Technology Agency2
Kyoto University Innovation Capital2
University of Tokyo Edge Capital2
Alumni Ventures1
ANRI1
Diamond Medino Capital1
Fast Track Initiative1
Global Brain1
JIC Venture Growth Investments1
Joyo Capital Partners1
LG Technology Ventures1
Medical Incubator Japan1
Mitsui Chemicals1
Playground Global1
Remiges Ventures1
TechnoScience1
Tokyo University of Science Innovation Capital1
Vision Incubate1

Investment Strategy

Japanese Agency for Medical Research and Development: Led accounts for 50% and participating for 50% of round participation.All available history.
Japanese Agency for Medical Research and Development: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led350%
Participating350%
Japanese Agency for Medical Research and Development: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
Japanese Agency for Medical Research and Development: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead267%
Co-led133%

Team

No team members found for this fund.